Resveratrol Metabolites Do Not Elicit Early Pro-apoptotic Mechanisms in Neuroblastoma Cells

被引:39
作者
Kenealey, Jason D. [2 ]
Subramanian, Lalita
Van Ginke, Paul R.
Darjatmoko, Soesiawati
Lindstrom, Mary J.
Somoza, Veronika [3 ]
Ghosh, Sunil K. [4 ]
Song, Zhenlei [4 ]
Hsung, Richard P. [4 ]
Kwon, Glen S. [4 ]
Eliceiri, Kevin W. [5 ]
Albert, Daniel M.
Polans, Arthur S. [1 ,2 ]
机构
[1] Univ Wisconsin, Ctr Clin Sci, Dept Ophthalmol & Visual Sci, Madison, WI 53792 USA
[2] Univ Wisconsin, Dept Biomol Chem, Med Sci Ctr, Madison, WI 53705 USA
[3] Univ Vienna, Sch Med & Publ Hlth, Inst Nutr & Physiol Chem, Vienna, Austria
[4] Univ Wisconsin, Div Pharmaceut Sci, Sch Pharm, Madison, WI 53705 USA
[5] Univ Wisconsin, Coll Engn, Lab Opt & Computat Instrumentat, Madison, WI 53706 USA
基金
美国国家卫生研究院;
关键词
resveratrol; neuroblastoma; calcium signaling; bioavailability; TUMOR-GROWTH; CANCER; CALCIUM; MITOCHONDRIA; INHIBITION; TOXICITY; CALPAIN; CA2+;
D O I
10.1021/jf104901g
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Resveratrol, a nontoxic polyphenol, has been shown to inhibit tumor growth in a xenograft mouse model of neuroblasoma. However, resveratrol is rapidly metabolized, mainly to its glucuronidated and sulfated derivatives. This study demonstrates that resveratrol alone, and not the glucuronidated or sulfated metabolites, is taken up into tumor cells, induces a rise in [Ca2+](i), and ultimately leads to a decrease in tumor cell viability. A new water-soluble resveratrol formulation was delivered directly at the site of the tumor in a neuroblastoma mouse model. The amount of unmodified resveratrol associated with the tumor increased more than 1000-fold. The increase of unmodified resveratrol associated with the tumor resulted in tumor regression. The number of residual tumor cells that remained viable also decreased as the ratio of the metabolites relative to unmodified resveratrol declined.
引用
收藏
页码:4979 / 4986
页数:8
相关论文
共 26 条
  • [1] Effectiveness of vitamin D analogues in treating large tumors and during prolonged use in murine retinoblastoma models
    Albert, DM
    Kumar, A
    Strugnell, SA
    Darjatmoko, SR
    Lokken, JM
    Lindstrom, MJ
    Patel, S
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (09) : 1357 - 1362
  • [2] Inhibition of cancer growth by resveratrol is related to its low bioavailability
    Asensi, M
    Medina, I
    Ortega, A
    Carretero, J
    Baño, MC
    Obrador, E
    Estrela, JM
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 (03) : 387 - 398
  • [3] The versatility and universality of calcium signalling
    Berridge, MJ
    Lipp, P
    Bootman, MD
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2000, 1 (01) : 11 - 21
  • [4] Neuroblastoma: Evolving Therapies for a Disease with Many Faces
    Goldsby R.E.
    Matthay K.K.
    [J]. Pediatric Drugs, 2004, 6 (2) : 107 - 122
  • [5] Toxicity and dose-response studies of 1α-hydroxyvitamin D2 in a retinoblastoma xenograft model
    Grostern, RJ
    Bryar, PJ
    Zimbric, ML
    Darjatmoko, SR
    Lissauer, BJ
    Lindstrom, MJ
    Lokken, JM
    Strugnell, SA
    Albert, DM
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2002, 120 (05) : 607 - 612
  • [6] GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
  • [7] Calpain and Caspase Orchestrated Death Signal to Accomplish Apoptosis Induced by Resveratrol and Its Novel Analog Hydroxstilbene-1 in Cancer Cells
    Guha, Prasun
    Dey, Anindya
    Dhyani, Manish V.
    Sen, Rupashree
    Chatterjee, Mitali
    Chattopadhyay, Subrata
    Bandyopadhyay, Sandip K.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (02) : 381 - 394
  • [8] Chemosensitization of tumors by resveratrol
    Gupta, Subash C.
    Kannappan, Ramaswamy
    Reuter, Simone
    Kim, Ji Hye
    Aggarwal, Bharat B.
    [J]. RESVERATROL AND HEALTH, 2011, 1215 : 150 - 160
  • [9] Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
    Jang, MS
    Cai, EN
    Udeani, GO
    Slowing, KV
    Thomas, CF
    Beecher, CWW
    Fong, HHS
    Farnsworth, NR
    Kinghorn, AD
    Mehta, RG
    Moon, RC
    Pezzuto, JM
    [J]. SCIENCE, 1997, 275 (5297) : 218 - 220
  • [10] Long-term Outcomes in Survivors of Neuroblastoma: A Report From the Childhood Cancer Survivor Study
    Laverdiere, Caroline
    Liu, Qi
    Yasui, Yutaka
    Nathan, Paul C.
    Gurney, James G.
    Stovall, Marilyn
    Diller, Lisa R.
    Cheung, Nai-Kong
    Wolden, Suzanne
    Robison, Leslie L.
    Sklar, Charles A.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (16): : 1131 - 1140